For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Events in recent years have strained investigative sites on unprecedented levels—from the sharp increase in studies to complex protocols, technology overload, and the explosion of data requirements.
Parexel recently partnered with The Tufts Center for the Study of Drug Development (CSDD) to conduct in-depth interviews of investigative sites to understand the current challenges they are facing, hear their thoughts on potential solutions, and consider measures of success for productive sponsor/CRO/site relationships.
This webinar brings together clinical development and site experts to discuss the sites’ feedback, including the biggest surprises, the greatest opportunities for improvement, and the steps that Parexel is taking to make a difference.
Key Learning Objectives
Karen McIntyre, Vice President of Global Site Alliances at Parexel will be joined by Ken Getz, Executive Director, Research Professor (PHCM) at Tufts Center for the Study of Drug Development, and Jeff Kingsley, DO, MBA, CPI, FACRP, Chief Development Officer Centricity Research.